D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
PayPal
PYPL
|
+$333M |
| 2 |
Microsoft
MSFT
|
+$311M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$310M |
| 4 |
Automatic Data Processing
ADP
|
+$260M |
| 5 |
Citigroup
C
|
+$255M |
Top Sells
| 1 |
APC
Anadarko Petroleum
APC
|
+$567M |
| 2 |
Fidelity National Information Services
FIS
|
+$410M |
| 3 |
Medtronic
MDT
|
+$374M |
| 4 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$288M |
| 5 |
Amazon
AMZN
|
+$278M |
Sector Composition
| 1 | Technology | 19.13% |
| 2 | Consumer Discretionary | 16.65% |
| 3 | Healthcare | 15.2% |
| 4 | Financials | 10.49% |
| 5 | Industrials | 8.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1101
CVB Financial
CVBF
$2.77B
| $4.91M | 0.01% |
235,176
+3,679
| +2% | +$76.8K |
|
|
UCB
1102
United Community Banks, Inc.
UCB
$3.94B
| $4.9M | 0.01% |
172,747
-45,877
| -21% | -$1.3M |
|
|
ZGNX
1103
DELISTED
Zogenix, Inc.
ZGNX
| $4.88M | 0.01% |
121,923
+53,747
| +79% | +$2.15M |
|
|
SHYF
1104
DELISTED
The Shyft Group
SHYF
| $4.87M | 0.01% |
354,932
-264,713
| -43% | -$3.63M |
|
|
AAMI
1105
Acadian Asset Management Inc.
AAMI
$1.74B
| $4.86M | 0.01% |
490,618
+294,944
| +151% | +$2.92M |
|
1106
Pultegroup
PHM
$27B
| $4.86M | 0.01% |
132,980
-385,091
| -74% | -$14.1M |
|
|
BNFT
1107
DELISTED
Benefitfocus, Inc.
BNFT
| $4.85M | 0.01% |
203,665
-320,855
| -61% | -$7.64M |
|
|
GHDX
1108
DELISTED
Genomic Health, Inc.
GHDX
| $4.85M | 0.01% |
71,478
-215,241
| -75% | -$14.6M |
|
|
JBTM
1109
JBT Marel Corporation
JBTM
$7.14B
| $4.84M | 0.01% |
48,699
+41,377
| +565% | +$4.11M |
|
|
INXN
1110
DELISTED
Interxion Holding N.V.
INXN
| $4.83M | 0.01% |
59,264
-55,327
| -48% | -$4.51M |
|
1111
Fair Isaac
FICO
$37.1B
| $4.82M | 0.01% |
15,896
-8,364
| -34% | -$2.54M |
|
1112
Owens & Minor
OMI
$407M
| $4.8M | 0.01% |
826,574
+799,603
| +2,965% | +$4.65M |
|
1113
Permian Resources
PR
$9.63B
| $4.78M | 0.01% |
+1,058,689
| New | +$4.78M |
|
1114
FNB Corp
FNB
$5.9B
| $4.76M | 0.01% |
412,922
+178,426
| +76% | +$2.06M |
|
1115
Boston Scientific
BSX
$152B
| $4.76M | 0.01% |
116,922
-305,601
| -72% | -$12.4M |
|
1116
BioCryst Pharmaceuticals
BCRX
$1.66B
| $4.75M | 0.01% |
1,657,379
+166,025
| +11% | +$476K |
|
1117
Central Pacific Financial
CPF
$825M
| $4.74M | 0.01% |
166,804
-18,793
| -10% | -$534K |
|
1118
iShares US Real Estate ETF
IYR
$3.65B
| $4.72M | 0.01% |
+50,500
| New | +$4.72M |
|
1119
American Homes 4 Rent
AMH
$12.6B
| $4.7M | 0.01% |
+181,531
| New | +$4.7M |
|
1120
Okta
OKTA
$15.9B
| $4.69M | 0.01% |
47,625
-34,367
| -42% | -$3.38M |
|
1121
Brink's
BCO
$4.83B
| $4.69M | 0.01% |
56,496
-13,258
| -19% | -$1.1M |
|
|
PYX
1122
DELISTED
Pyxus International, Inc.
PYX
| $4.67M | 0.01% |
357,182
+94,350
| +36% | +$1.23M |
|
|
AGEN
1123
Agenus
AGEN
$144M
| $4.67M | 0.01% |
92,192
-59,322
| -39% | -$3M |
|
1124
Alaska Air
ALK
$7.31B
| $4.66M | 0.01% |
+71,823
| New | +$4.66M |
|
|
PDLI
1125
DELISTED
PDL BioPharma, Inc.
PDLI
| $4.66M | 0.01% |
2,156,167
+205,719
| +11% | +$444K |
|